ASOs targeting PKMYT1AR effectively suppressed tumor growth in preclinical models.By binding to PKMYT1AR, thereby disrupting the PKMYT1AR/miR-485-5p/PKMYT1 axis that normally promotes cancer stem cell maintenance via Wnt signaling activation. This evidence concerns the gene PKMYT1 and neoplasm.